Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.
Research article published in Circulation (2013)
Abstract
BACKGROUND: Generation of active procoagulant cofactor factor Va (FVa) and its subsequent association with the enzyme activated factor X (FXa) to form the prothrombinase complex is a pivotal initial event in blood coagulation and has been the subject of investigative effort, speculation, and controversy. The current paradigm assumes that FV activation is initiated by limited proteolysis by traces of (meizo) thrombin. METHODS AND RESULTS: Recombinant tick salivary protein TIX-5 was produced and anticoagulant properties were studied with the use of plasma, whole blood, and purified systems. Here, we report that TIX-5 specifically inhibits FXa-mediated FV activation involving the B domain of FV and show that FXa activation of FV is pivotal for plasma and blood clotting. Accordingly, tick feeding is impaired on TIX-5 immune rabbits, displaying the in vivo importance of TIX-5. CONCLUSIONS: Our data elucidate a unique molecular mechanism by which ticks inhibit the host's coagulation system. From our data, we propose a revised blood coagulation scheme in which direct FXa-mediated FV activation occurs in the initiation phase during which thrombin-mediated FV activation is restrained by fibrinogen and inhibitors.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
Generation of active procoagulant cofactor factor Va (FVa) and its subsequent association with the enzyme activated factor X (FXa) to form the prothrombinase complex is a pivotal initial event in blood coagulation and has been the subject of investigative effort, speculation, and controversy. The...
Why This Matters for Hirudotherapy
This study investigated the recombinant tick salivary protein TIX-5, demonstrating that it specifically inhibits factor Xa-mediated activation of factor V—a pivotal initiating event in blood coagulation—and that this inhibition impairs tick feeding in immune rabbits in vivo. The authors propose a revised coagulation model in which direct FXa-mediated FV activation occurs during initiation while thrombin-mediated FV activation is restrained. For ASH's domain, while this study concerns a blood-feeding arthropod salivary anticoagulant—a field cognate to leech secretome research—the organism is a tick, not a leech, and TIX-5's mechanism (FXa-mediated FV activation blockade) is distinct from known leech anticoagulants such as hirudin. Relevance is therefore limited to comparative hematophagous arthropod anticoagulant biology rather than direct application to hirudotherapy.
Citation
Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.
Schuijt et al. · Circulation, 2013
Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026